From this analysis, we identified 15 differentially expressed M7RGs, with 4 of them (NUDT3, CYFIP1, NCBP1, and IFIT5) being upregulated in AD patients, while 11 of them (METTL1, DCPS, NUDT10, NUDT11, EIF4E, EIF4E2, EIF4E3, LARP1, EIF4G3, LSM1, and NCBP2L) were downregulated compared to non-AD patients (Figures 2A, B, E). This evidence concerns the gene NCBP2L and Alzheimer disease.